Vice President, Regulatory Affairs

Dr. Hoopes joined Polaris in 2022 bringing regulatory expertise from her experience in both the contract research organization and industry sectors.  Prior to joining Polaris, she supported 20+ regulatory submission programs, including early-stage programs leading to first-in-human studies to late-stage marketing applications, by leading cross-functional teams, authoring complex regulatory documents, and provided strategic regulatory advice.

She brings integrated product development experience in drugs, biologics, and devices across a variety of therapeutic areas including oncology, allergy and immunology, genetic and rare diseases, ophthalmology, respiratory, dermatology, reproductive disorders, cardiovascular, and neurology.

Dr. Hoopes earned her Ph.D. in Cell and Molecular Physiology at The University of North Carolina at Chapel Hill and she completed her postdoctoral training at the National Institute of Environmental Health Sciences.